ASLAN Pharmaceuticals Limited - stock earnings
ASLN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 26, 2024 BeforeMarket | - / - | - | - / - | - |
ASLN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -13.5 million USD | ? USD |
| 2023Q4 | -13.5 million USD | ? USD |
| 2023Q3 | -9.7 million USD | ? USD |
| 2023Q2 | -1.9 million USD | 12.0 million USD |
| 2023Q1 | -19.1 million USD | ? USD |
| 2022Q4 | -14.5 million USD | ? USD |
| 2022Q3 | -10.9 million USD | ? USD |
| 2022Q2 | -12.9 million USD | ? USD |
| 2022Q1 | -12.9 million USD | ? USD |
| 2021Q4 | -9.1 million USD | ? USD |
| 2021Q3 | -8.6 million USD | ? USD |
| 2021Q2 | -5.4 million USD | ? USD |
| 2021Q1 | -5.7 million USD | ? USD |
| 2020Q4 | -5.7 million USD | ? USD |
| 2020Q3 | -4.0 million USD | ? USD |
| 2020Q2 | -4.0 million USD | ? USD |
| 2020Q1 | -29.6 million USD | ? USD |
| 2019Q4 | -29.6 million USD | ? USD |
| 2019Q3 | -5.2 million USD | ? USD |
| 2019Q2 | -7.9 million USD | ? USD |
| 2019Q1 | -11.7 million USD | 3.0 million USD |
| 2018Q4 | -11.7 million USD | ? USD |
| 2018Q3 | -11.2 million USD | ? USD |
| 2018Q2 | -10.8 million USD | ? USD |
| 2018Q1 | -8.8 million USD | ? USD |
| 2017Q4 | -15.4 million USD | ? USD |
| 2017Q3 | -7.9 million USD | ? USD |
| 2017Q2 | -9.2 million USD | ? USD |
| 2017Q1 | -8.3 million USD | ? USD |
| 2016Q4 | -6.7 million USD | 903685 USD |
| 2016Q3 | 5.3 million USD | 10.3 million USD |
| 2016Q2 | -3.3 million USD | 253945 USD |
| 2016Q1 | -4.0 million USD | ? USD |
ASLN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -44.2 million USD | 12.0 million USD |
| 2022 | -51.4 million USD | 12.0 million USD |
| 2021 | -34.7 million USD | ? USD |
| 2020 | -17.9 million USD | ? USD |
| 2019 | -47.1 million USD | 3.0 million USD |
| 2018 | -42.2 million USD | ? USD |
| 2017 | -40.7 million USD | ? USD |
| 2016 | -9.0 million USD | 11.5 million USD |
| 2015 | -13.3 million USD | ? USD |
| 2014 | -7.4 million USD | ? USD |
ASLN
Price: $0.46
52 week price:
Earnings Per Share: -3.00 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 108290
Market Capitalization: 9.4 million